Suvorexant and Sleep's Benefits to Therapeutic Exposure for Posttraumatic Stress Disorder
Status:
Completed
Trial end date:
2021-05-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine effects of blocking the orexin system with suvorexant
after exposure-based intervention for posttraumatic stress disorder (PTSD) on sleep, PTSD
symptoms, and intersession habituation.
Phase:
Phase 4
Details
Lead Sponsor:
Howard University
Collaborators:
Georgetown-Howard Universities Center for Clinical and Translational Science National Institute of Mental Health (NIMH)